We are live on ! Find out more
ZSPH

ZS PHARMA INC COMS TK (DE)
ZSPH

Delisted

ZSPH was delisted on the 16th of December, 2015.

120 hedge funds and large institutions have $982M invested in ZS PHARMA INC COMS TK (DE) in 2015 Q2 according to their latest regulatory filings, with 44 funds opening new positions, 47 increasing their positions, 23 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

243% more call options, than puts

Call options by funds: $21.6M | Put options by funds: $6.3M

175% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 16

104% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 23

38% more capital invested

Capital invested by funds: $711M → $982M (+$270M)

30% more funds holding

Funds holding: 92120 (+28)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
120
Holders Change
+28
Holders Change %
+30.43%
% of All Funds
3.23%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
44
Increased
47
Reduced
23
Closed
16
Calls
$21.6M
Puts
$6.3M
Net Calls
+$15.3M
Net Calls Change
+$15.3M
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$196M +$557K +11,318 +0.3%
DPA
2
Devon Park Associates
$135M
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$71M -$296K -6,020 -0.4%
Vanguard Group
4
Vanguard Group
Pennsylvania
$50.6M +$6.47M +131,404 +16%
SCM
5
Scopia Capital Management
New York
$48.5M -$2.45M -49,682 -5%
State Street
6
State Street
Massachusetts
$44M +$36.9M +748,540 +826%
BFA
7
BlackRock Fund Advisors
California
$39.5M +$15.6M +316,774 +72%
UIM
8
USS Investment Management
United Kingdom
$30.9M +$29.1M +590,396 New
Millennium Management
9
Millennium Management
New York
$28.2M +$22.2M +450,142 +509%
BGIM
10
Brandywine Global Investment Management
Pennsylvania
$25.5M +$24M +486,906 New
SAM
11
Sectoral Asset Management
Quebec, Canada
$24.4M +$12.1M +246,536 +112%
PHS
12
PFM Health Sciences
California
$23.6M -$21.3M -433,504 -49%
PA
13
Perceptive Advisors
New York
$19M +$8.62M +175,000 +94%
RG
14
Redmile Group
California
$15.9M -$5.06M -102,700 -25%
Loomis, Sayles & Company
15
Loomis, Sayles & Company
Massachusetts
$15.3M +$2.36M +47,895 +20%
Bank of New York Mellon
16
Bank of New York Mellon
New York
$14.4M +$2.99M +60,795 +28%
BIT
17
BlackRock Institutional Trust
California
$14.1M +$8.71M +176,823 +191%
WRF
18
Waddell & Reed Financial
Kansas
$10.8M -$113K -2,300 -1%
Citadel Advisors
19
Citadel Advisors
Florida
$10.5M +$5.66M +114,854 +133%
CA
20
Commerzbank Aktiengesellschaft
Germany
$10.3M +$9.64M +195,860 New
EA
21
Emerald Advisers
Pennsylvania
$9.58M +$86.4K +1,755 +1%
RSCM
22
Rock Springs Capital Management
Maryland
$8.33M +$49.2K +1,000 +0.6%
EMFAT
23
Emerald Mutual Fund Advisers Trust
Pennsylvania
$7.07M -$877K -17,800 -12%
DM
24
Deerfield Management
New York
$6.92M -$758K -15,385 -10%
WSA
25
Wall Street Associates
California
$6.85M -$246K -5,000 -4%

ZSPH Hedge Fund Activity: Q2 2015 in Review

120 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in ZS PHARMA INC COMS TK (DE) (ZSPH) for Q2 2015, worth a combined $982M — up 38% from $711M a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new ZSPH positions and 16 closed out — a net gain of 28 holders — while 47 added to existing stakes and 23 trimmed.

The largest buyer was State Street, adding an estimated $36.9M. The largest seller was Janus Henderson Investors US, exiting entirely with an estimated $27.7M sold.

  • 120 institutional investors held ZS PHARMA INC COMS TK (DE) (ZSPH) as of Q2 2015, up from 92 in Q1 2015.
  • Funds reported $982M of ZS PHARMA INC COMS TK (DE) stock for Q2 2015, up 38% quarter-over-quarter.
  • 44 funds opened new ZS PHARMA INC COMS TK (DE) positions in Q2 2015 and 16 closed out, a net change of +28 holders.
  • The largest ZS PHARMA INC COMS TK (DE) buyer in Q2 2015 was State Street, an estimated $36.9M added.
  • The largest ZS PHARMA INC COMS TK (DE) seller in Q2 2015 was Janus Henderson Investors US, an estimated $27.7M sold.

Based on aggregated 13F filings for Q2 2015.